missing translation for 'onlineSavingsMsg'
Learn More

Fasiglifam, MedChemExpress

Product Code. 16480986
Encompass_Preferred
missing translation for 'orderingAttributeHoverText'
Quantité:
2 mg
5 mg
10 mg
50 mg
100 mg
200 mg
This item is not returnable. View return policy

Product Code. 16480986

missing translation for 'mfr': Medchem Express HY10480

Veuillez vous pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant!

This item is not returnable. View return policy

MedChemExpress Fasiglifam (TAK-875) is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 72 nM.

Fasiglifam (TAK-875) is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 72 nM.

Specifications

Nom chimique ou matériau Fasiglifam
CAS 1000413-72-8
Couleur Red
Notes de qualité de la pureté Research
Formule moléculaire C29H32O7S
Quantité 200 mg
Synonyme TAK-875
Informations sur la solubilité DMSO : ≥ 128 mg/mL (243.98 mM)
SMILES CC1=C(C(C)=CC(OCCCS(C)(=O)=O)=C1)C2=CC(COC3=CC=C4[C@@H](COC4=C3)CC(O)=O)=CC=C2
Poids moléculaire (g/mol) 524.63
Poids de la formule 524.63
Pourcentage de pureté 95.05%
Qualité Research
Forme physique Liquid
À utiliser avec (application) Metabolism-sugar/lipid metabolism
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.